Researchers have found a way to identify rogue cancer cells which survive treatment after the rest of the tumour is destroyed, by using a new technique that enables them to identify and characterise individual cancer cells. Recent breakthroughs are revolutionising cancer treatment, enabling doctors to personalise chemotherapy for each patient. However, although these new treatments […]
A new £115 million biomedical research centre will pave the way for treatments for some of the biggest population health issues around the globe, potentially improving the everyday lives of millions. Opened with the support of a £20m gift from the Li Ka Shing Foundation, the centre will bring together researchers from related teams to […]
An online project has been launched to study antibiotic resistance in Tuberculosis (TB) with the help of the public. The project website, bashthebug.net, shows volunteers images of a series of small, circular wells, each containing M.tuberculosis (the bug that causes TB) and a different dose of an antibiotic. The users are then asked to identify […]
Professor Andrea Cipriani is the Oxford Health NHS Foundation Trust’s new Associate R&D Director. Professor Cipriani is a senior clinical researcher at the Department of Psychiatry at Oxford University, and honorary consultant psychiatrist at the Trust. His field of expertise in research is evidence synthesis and clinical trials, with a special focus on the evaluation […]
A new study could change the lives of millions of people living with inflammatory bowel diseases (IBD) who don’t respond to the current standard of care. Researchers at the Kennedy Institute of Rheumatology and Translational Gastroenterology Unit, University of Oxford have identified a potential therapeutic target for IBD. The findings are of particular importance to […]
An Ebola vaccine has been shown to provide immunity for up to a year after immunisation in all of those immunised in a new study. The study was led by the Oxford Vaccine Group at the University of Oxford. It tested the prime-boost Ebola vaccine regimen being developed by Janssen Vaccines & Prevention B.V. that […]
Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people. Retinitis pigmentosa is currently untreatable and leads to a slow and irreversible loss of vision. For the full story on University of Oxford website
Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine. The programme aims to develop new therapies for acute and chronic conditions including pain, cancer and inflammatory disease. Through an initial investment of up to £10 million provided by Kingsley, funded through its […]
In a world-first, Whole Genome Sequencing (WGS) is now being used to identify different strains of tuberculosis, announced Public Health England today. This is the first time that WGS has been used as a diagnostic solution for managing a disease on this scale anywhere in the world. This builds on WGS based services for public […]
Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people. Retinitis pigmentosa is currently untreatable and leads to a slow and irreversible loss of vision. For the full story on Oxford Biomedical Research Centre website